The move gives doctors and high-risk patients an additional option for treating mild-to-moderate illness caused by the coronavirus By Laurie McGinley, January 21, 2022 at 7:20 p.m. EST Federal regulators Friday approved the use of the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors...